Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5022
-0.0748 (-12.96%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $54.15 million as of June 18, 2026. Its market cap has increased by 821.90% in one year.
Market Cap
54.15M
Enterprise Value
54.13M
1-Year Change
821.90%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $54.15M, an increase of 56.98%. That is a compound annual growth rate of 29.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 54.15M | 2.49% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediciNova | 65.96M |
| BeyondSpring | 65.38M |
| Acrivon Therapeutics | 65.06M |
| ImageneBio | 64.18M |
| Seres Therapeutics | 62.56M |
| Edesa Biotech | 61.13M |
| MiNK Therapeutics | 60.83M |
| Entera Bio | 59.07M |